Braskem creditors, shareholders near deal on $11bn debt restructuring

Braskem and creditors are nearing a restructuring agreement covering about $11 billion of debt, but substantial differences remain and a deal is not guaranteed. Proposals differ on initial support: creditors’ plan totals about $4 billion, versus about $5 billion under Braskem’s, including a proposed $2.25 billion share offering and debt-to-equity conversions. The parties have until November 22 to finalize an agreement; Braskem began an out-of-court restructuring process in August.

Analysis

The key equity question is not simply whether Braskem avoids a filing; it is who funds the rescue and who controls the post-restructuring company. A creditor-led conversion could reduce solvency risk while transferring substantial ownership to creditors, limiting the value of that improvement for existing BAK shareholders. Conversely, a credible, funded agreement would remove a major tail risk and could reprice the equity sharply before operating fundamentals change. Treat that as a volatility event, not evidence of a near-term earnings recovery.

For Petrobras, the risk is contingent capital and governance: a requirement to guarantee cash upfront could create a direct funding burden, while a plan preserving current control may carry different economic costs. The article does not establish Petrobras’s eventual commitment or its financial materiality; verify the final funding obligation and any resulting ownership or governance terms before trading PBR.A on this basis. Creditors may gain a cleaner balance sheet but face conversion and recovery outcomes tied to Braskem’s post-deal performance.

The near-term catalyst is a signed agreement by the stated November 22 deadline; failure to bridge the upfront-funding gap could restore restructuring and operational-disruption risk. Over 1–3 months, assess completed funding, creditor approvals, and the post-deal capital structure. Over 6–18 months, the test is whether deleveraging translates into stable operations and cash generation—not merely a liability transfer. Contrarian point: a deal can be credit-positive but equity-neutral or dilutive. No valuation or market-pricing data are supplied, so conviction on outright direction is limited.

Key Decisions for Investors

• Avoid adding to BAK common ahead of definitive terms; the rescue may reduce insolvency risk but still leave existing holders heavily diluted. Reassess once the filing specifies conversion size, share count, and committed cash.
• Event-driven relative-value watch: consider short BAK versus long PBR.A only if final terms require substantial shareholder-backed cash while creditors receive large equity conversions. Keep exposure small and close or reassess on a signed agreement; the trade can lose if relief from bankruptcy risk drives BAK higher or Petrobras assumes a material funding burden.
• Use the November 22 deadline as a catalyst, not a guaranteed resolution date. If negotiations fail or the deadline passes without a funded agreement, reassess BAK for renewed distress risk; if an agreement is signed, verify funding commitments, creditor consent, and control rights before treating the headline as de-risking.
• Falsifiers: a fully funded deal with limited incremental shareholder obligations and less dilution than feared weakens the negative BAK equity view; a renewed funding impasse or disclosed large Petrobras guarantee weakens the relative-value case and raises downside risk for both securities.